Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients 
under neuroleptic treatment: need for levodopa therapy?

Schwarz, J.; Scherer, J.; Trenkwalder, C.; Mozley, P. D.; Tatsch, K.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy?

MPS-Authors

Schwarz, J.
Max Planck Institute of Psychiatry, Max Planck Society;

Scherer, J.
Max Planck Institute of Psychiatry, Max Planck Society;

Trenkwalder, C.
Max Planck Institute of Psychiatry, Max Planck Society;

Mozley, P. D.
Max Planck Institute of Psychiatry, Max Planck Society;

Tatsch, K.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Schwarz, J., Scherer, J., Trenkwalder, C., Mozley, P. D., & Tatsch, K. (1998). Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy? Psychiatry Research, 83, 23-28.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-A8D8-D

Abstract

There is no abstract available